Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Suku Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Ebitda
Harga Saham
99.14
Perubahan Harian
6.84
7.41%
Bulanan
12.93%
Tahunan
8.24%
Q2 Perkiraan
84.88
Keuangan
Harga Saham
USD
Aktiva
USD 12B
Kas Dan Setara
USD 860.32M
Biaya Penjualan
USD 323.46M
Aset Lancar
USD 2.13B
Kewajiban Lancar
USD 1.24B
UTANG
USD 3.4B
Dividen - Hasil
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
Karyawan
11K
Eps Laba Per Saham
USD 1.06
Modal Dan Cadangan
USD 7.25B
Laba Kotor Pada Penjualan
USD 387.66M
Beban Bunga Utang
USD 24.72M
Pendapatan Bunga
USD 5.75M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 12.04B
Batas Pemasukan
USD 40.72M
Biaya Operasional
USD 628.35M
Laba Operasional
USD 82.77M
Modal Saham Biasa
USD 111.8M
Pe Harga Untuk Laba
30.79
Laba Sebelum Pajak
USD 91.56M
Pendapatan Penjualan
USD 711M
Beban Penjualan Dan Administrasi
USD 253.88M
Saham
USD 387.51M
Kreditur Perdagangan
USD 169.68M
Debitur Perdagangan
USD 691.38M
Ebitda
Perubahan
Tanggal
Agilent
USD 540M
74M
2025-09
Align Technology
USD 260.87M
77.03M
2025-12
Bio Techne
USD 103.42M
7.47M
2025-12
Bio-Rad Laboratories
USD 983.8M
1.36B
2025-12
Bruker
USD 211.6M
207.4M
2025-12
Celltrion
KRW 374.56B
352.67B
2025-09
Charles River Laboratories
USD 258.06M
24.83M
2025-12
Cspc Pharmaceutical
CNY 2.19B
21.88M
2024-12
Danaher
USD 1.92B
204M
2026-03
Dentsply International
USD 129M
6M
2026-03
Deva Holding AS
TRY 882.9M
201.7M
2023-09
Dianthus Therapeutics
USD -40.19M
5.36M
2025-09
Divis Laboratories Ltd
INR 8.9B
20M
2025-12
Edwards Lifesciences
USD 70.1M
394.2M
2025-12
Illumina
USD 469M
137M
2025-12
Intuitive Surgical
USD 1.09B
165.5M
2025-12
IQVIA Holdings
USD 932M
114M
2026-03
Kangmei Pharma
CNY 17.3M
20.56M
2025-06
Knight Therapeutics
CAD 24.45M
3.46M
2025-12
Laboratorios Farma
EUR 34.94M
102.95M
2025-06
Laboratory Of America
USD 605.6M
17.5M
2026-03
Malin Corporation
EUR -1.1M
200K
2024-12
Medical Developments International
AUD 1.78M
3.78M
2024-12
Mesa Laboratories
USD 9.58M
1.47M
2024-09
Mettler Toledo International
USD 322.64M
26.75M
2025-09
Myriad Genetics
USD 14.3M
4M
2025-12
Neuren Pharmaceuticals
AUD 11.14M
165.56M
2025-12
OraSure Technologies
USD -17.7M
4.06M
2025-12
Organigram Holdings
CAD 5.26M
884K
2025-12
Pacific Biosciences Of California
USD -35.4M
5.78M
2025-09
Pharma Mar
EUR 2.71M
42.25M
2026-03
Qiagen NV
USD 249.69M
56.53M
2025-12
Quest Diagnostics
USD 557M
20M
2026-03
Quidel
USD 108.7M
44.6M
2026-03
Repligen
USD 40.01M
469K
2026-03
Revvity
USD 272.91M
24M
2026-03
Sartorius
EUR 267.3M
10.1M
2026-03
Sino Biopharmaceutical
CNY 2.59B
1.57B
2024-12
Thermo Fisher Scientific
USD 2.7B
464M
2026-03
Tilray
USD 8.36M
1.82M
2025-09
Waters
USD 380.97M
85.83M
2025-12
Zealand Pharma A/S
-727.47M
285.54M
2025-12
Zhangzhou Pientzehuang Pharmaceutical
CNY 882.7M
351.1M
2026-03
×